Background <p>We investigated factors associated with post-transplant growth in pediatric kidney transplant (KTx) recipients with a focus on plasma bicarbonate (HCO3<sup>−</sup>) and estimated the effect of alkali treatment on growth.</p> Methods <p>In this study of the CERTAIN Registry, data were collected up to 5&#xa0;years post-transplant. Generalized Additive Mixed Models were applied to assess the association between post-transplant growth and covariates. A trial-emulation analysis was performed to estimate the causal effect of alkali supplementation on growth.</p> Results <p>We report on 2147 primary KTx recipients with a median age at KTx of 10.2 (IQR 5.1;14.3) years. No statistically significant association was found between growth and HCO3<sup>−</sup> (<i>p</i> = 0.21), but the shape of the estimated conditional association showed a decreasing estimated growth with increasing HCO3<sup>−</sup>. Glucocorticoid treatment and allograft rejection showed an inverse association with growth. Living donor KTx, glomerulopathy, recombinant growth hormone use, low height <i>z</i>-score at KTx, younger age, and higher eGFR were positively associated with growth. The trial-emulation analysis included patients at 30&#xa0;days and 3, 6, and 9&#xa0;months post-transplant with HCO3<sup>−</sup>  &lt; 22&#xa0;mmol/L and no prior alkaline treatment. Alkaline treatment was initiated in 194, 93, 47, and 25 patients, respectively. After adjustment for confounders, there was no significant difference in growth at 1-year post-transplant in treated and untreated patients.</p> Conclusions <p>We found no association between HCO3<sup>−</sup> and growth nor evidence of improved growth after treatment of metabolic acidosis. Living donor KTx was positively associated with post-transplant growth, while there was an inverse association with allograft rejection.</p> Graphical Abstract <p></p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Factors associated with statural growth in pediatric kidney transplant recipients with focus on metabolic acidosis

  • Agnieszka Prytuła,
  • Dries Reynders,
  • Els Goetghebeur,
  • Kai Krupka,
  • Justine Bacchetta,
  • Nele Kanzelmeyer,
  • Isabella Guzzo,
  • Raffaella Labbadia,
  • Elisa Benetti,
  • Mohan Shenoy,
  • Anne-Laure Sellier-Leclerc,
  • Jun Oh,
  • Mieczysław Litwin,
  • Jacek Rubik,
  • Atif Awan,
  • Ilmay Bilge,
  • Lutz T. Weber,
  • Dominik Müller,
  • Thomas Simon,
  • Lars Pape,
  • Burkhard Tönshoff,
  • Demet Alaygut,
  • Gema Ariceta,
  • Martin Bald,
  • Nina Battelino,
  • Ortraud Beringer,
  • Laszlo Berta,
  • Antonia Bouts,
  • Olivia Boyer,
  • Salim Caliskan,
  • Ali Duzova,
  • Henry Fehrenbach,
  • Wesley Hayes,
  • Kristina Heindl-Rusai,
  • Julien Hogan,
  • Ulrike John-Kroegel,
  • Jon Jin Kim,
  • Michael Kaabak,
  • Günter Klaus,
  • Martin Konrad,
  • Stephen Marks,
  • Hulya Nalcacioglu,
  • Aytül Noyan,
  • Ozan Ozkaya,
  • Martin Pohl,
  • Michael Pohl,
  • Licia Peruzzi,
  • Nikoleta Printza,
  • Alexandr Rumyantsev,
  • Katja Sauerstein,
  • Oguz Söylemezoglu,
  • Gesa Schalk,
  • Hagen Staude,
  • Sara Testa,
  • Marcus Weitz,
  • Fatos Yalcinkaya,
  • Jakub Zieg

摘要

Background

We investigated factors associated with post-transplant growth in pediatric kidney transplant (KTx) recipients with a focus on plasma bicarbonate (HCO3) and estimated the effect of alkali treatment on growth.

Methods

In this study of the CERTAIN Registry, data were collected up to 5 years post-transplant. Generalized Additive Mixed Models were applied to assess the association between post-transplant growth and covariates. A trial-emulation analysis was performed to estimate the causal effect of alkali supplementation on growth.

Results

We report on 2147 primary KTx recipients with a median age at KTx of 10.2 (IQR 5.1;14.3) years. No statistically significant association was found between growth and HCO3 (p = 0.21), but the shape of the estimated conditional association showed a decreasing estimated growth with increasing HCO3. Glucocorticoid treatment and allograft rejection showed an inverse association with growth. Living donor KTx, glomerulopathy, recombinant growth hormone use, low height z-score at KTx, younger age, and higher eGFR were positively associated with growth. The trial-emulation analysis included patients at 30 days and 3, 6, and 9 months post-transplant with HCO3  < 22 mmol/L and no prior alkaline treatment. Alkaline treatment was initiated in 194, 93, 47, and 25 patients, respectively. After adjustment for confounders, there was no significant difference in growth at 1-year post-transplant in treated and untreated patients.

Conclusions

We found no association between HCO3 and growth nor evidence of improved growth after treatment of metabolic acidosis. Living donor KTx was positively associated with post-transplant growth, while there was an inverse association with allograft rejection.

Graphical Abstract